Press Releases
Candid Therapeutics Debuts with $370M Capital Raise to Clinically Evaluate Potentially Transformative Autoimmune Therapies
EpimAb Biotherapeutics and Vignette Bio Announce Strategic Collaboration to Develop EMB-06, a BCMA×CD3 Bispecific Antibody
Accent Therapeutics Announces $75 Million Series C Financing to Advance Small Molecule Precision Cancer Therapies
Mirae Asset Capital Life Science Emerges from Stealth with $50M Fund
Business Wire | September 9, 2024
EpimAb Biotherapeutics and Vignette Bio Announce Strategic Collaboration to Develop EMB-06, a BCMA×CD3 Bispecific Antibody
GlobeNewswire | September 3, 2024
Accent Therapeutics Announces $75 Million Series C Financing to Advance Small Molecule Precision Cancer Therapies
PR Newswire | January 23, 2024
Mirae Asset Capital Life Science Emerges from Stealth with $50M Fund
Business Wire | January 18, 2024